⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CATX News
Perspective Therapeutics, Inc.
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
globenewswire.com
CATX
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
globenewswire.com
CATX
Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor
globenewswire.com
CATX
Form 8-K
sec.gov
CATX
Parent Project Muscular Dystrophy Hosts 2026 Annual Conference in Orlando, Florida
prnewswire.com
CAPR
SRPT
CATX
BMRA
EDSA
ENTX
SLDB
WVE
Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study
globenewswire.com
CATX
Form 8-K
sec.gov
CATX
Form 8-K
sec.gov
CATX
Form 8-K
sec.gov
CATX
Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
globenewswire.com
CATX